News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Basilea Has Successful Debut With $161M IPO In Switzerland



10/19/2005 5:10:38 PM

Basilea Pharmaceutica AG raised gross proceeds of CHF205.8 million (US$161.2 million) in Europe's second significant biotechnology initial public offering of 2004. The Basel, Switzerland, drug development company sold 28.5 percent of its equity, or 2.1 million shares, priced at CHF98 per share, having initially set a price range of CHF90 to CHF115.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES